From Genetic Tests to Tailored Care: Decoding a field with big potential -- and even bigger implications
By Kelly Bothum,
Delaware Online
| 06. 01. 2010
[Quotes CGS's Jesse Reynolds]
Imagine a doctor using your genetic profile to decide which medicine to prescribe or to determine your risk for developing a life-threatening health problem. It's not a medical fantasy -- genetic tests already are used to gauge how patients will respond to certain drugs or to look for mutations in specific genes that can increase the risk for developing aggressive types of cancer.
But while the potential of so-called personalized medicine seems immense, some big questions are years away from being fully answered. Right now, researchers are still trying to understand key issues related to this next frontier of modern medicine, including how genetic profiling can help patients better understand their health risks, how medical professionals will be able to interpret results and what, if any, ethical implications arise in having this much genetic information.
"Personalized medicine is still in its infancy," said Dr. Ayyappan Rajasekaran, director of the Nemours Center for Childhood Cancer Research, which is studying biomarkers that can help identify more aggressive forms of the disease in kids. "We have a chance to do fantastic work."
At...
Related Articles
By Darren Incorvaia, Fierce Biotech | 07.16.2026
Jennifer Doudna, Ph.D., the Nobel Laureate best known for co-inventing the CRISPR system that has become the foundation for gene editing, is dipping her toes into a new, buzzy field: AI-powered protein design.
In a new paper, published today...
By Risa Cromer, The Conversation | 07.17.2026
By Emily Packard Dawson and Lainie Friedman Ross , The Hastings Center for Bioethics | 07.16.2026
Major news outlets recently reported – based on a bioRxiv preprint – that scientists had edited genes in human embryos with “startling precision.” The scientists’ decision to release this work ahead of peer review, coupled with the extensive media coverage...
Media coverage of recent developments in embryo gene editing might seem to suggest that gene-edited babies are close to becoming a reality. As tech billionaires eager to profit off of techno-eugenics invest in “designer baby” technologies, attempts to normalize heritable genome editing – which remains unsafe and raises significant ethical and societal concerns – are especially dangerous. It’s worth taking a closer look at these developments and what they mean, in a way that pushes back on narratives normalizing the...
